A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants
Latest Information Update: 25 Sep 2026
At a glance
- Drugs BHB 1893 (Primary)
- Indications Hypertrophic cardiomyopathy
- Focus Pharmacokinetics
- Sponsors Shandong Suncadia Medicine
Most Recent Events
- 21 Sep 2026 Status changed from active, no longer recruiting to completed.
- 17 Aug 2026 Planned End Date changed from 1 Jul 2026 to 1 Sep 2026.
- 17 Aug 2026 Planned primary completion date changed from 1 Jul 2026 to 1 Sep 2026.